The latest drug for treating prostate cancer

The causes of prostate cancer are many and complex, which makes men have a little fear of this disease. Once the disease occurs, patients must pay attention to early detection and early treatment, which is the key part of clinical treatment of this disease. What is the choice of drugs during treatment is also a question that many patients want to know. Let's take a look at the latest drugs for treating prostate cancer.

1. Androgen receptor blockers

Androgen receptor blockers can effectively inhibit androgens from entering the cell nucleus, thereby blocking their biological effects. Androgen receptor blockers are easy to use and have few adverse reactions in patients for the treatment of prostate cancer. Currently, this drug is widely used in clinical practice. Androgen receptor blockers can be divided into two types: steroidal and non-steroidal. Drugs include steroids such as cyproterone acetate and megestrol acetate, and non-steroidal drugs include flutamide, nilutamide, etc.

Bicalutamide is a selective anti-androgen drug that is widely used clinically. Its efficacy is 5 times that of flutamide and is relatively better.

2. LHRH analogs

Luteinizing hormone-releasing hormone analogs can reduce the testosterone concentration in the blood to castration levels after administration. Commonly used drugs in clinical practice include leuprorelin acetate, buserelin, goserelin acetate, etc.

3. Vascular endothelial growth factor inhibitors

Bevacizumab is a growth factor inhibitor. Its mechanism of action is mainly to neutralize growth factors in the human body and block their binding to receptors on the surface of endothelial cells. It can reduce tumor angiogenesis, causing tumor tissue to lose nutrient supply and gradually disappear. There are many adverse reactions, including hypertension, congestive heart failure, leukopenia, stomatitis, vomiting and diarrhea.

4. Immunotherapy drugs

Provenge fights prostate cancer by stimulating the patient's own immune system, stimulating the patient's immune response and specifically killing cancer cells in the patient's body.

5. Chemotherapy drugs

Docetaxel, a commonly used chemotherapy drug, inhibits the division and proliferation of cancer cells by inhibiting microtubules, which are necessary for cell division. Docetaxel injection can be used in combination with prednisone in clinical practice, mainly for the treatment of advanced metastatic prostate cancer.

This is an introduction to the drugs for prostate cancer. I hope that patients with this disease will not lose confidence in treatment. At the same time, they must strictly follow the doctor's instructions on medication and not use it casually. As long as the patient actively cooperates with the doctor's treatment, I believe the disease can be cured soon.